-
公开(公告)号:EP1429737A1
公开(公告)日:2004-06-23
申请号:EP02773665.1
申请日:2002-09-28
申请人: McNeil-PPC, INC. , Thomas, Martin
发明人: LEE, Der-Yang , LI, Shun-Por , MCTEIGUE, Daniel , PARIKH, Narendra , SOWDEN, Harry, S. , THOMAS, Martin , WYNN, David
CPC分类号: A23G3/04 , A23G1/54 , A23G3/0029 , A23G3/368 , A23G3/54 , A23L29/30 , A61J3/005 , A61J3/06 , A61J3/10 , A61K9/0004 , A61K9/0056 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2031 , A61K9/2054 , A61K9/2068 , A61K9/2072 , A61K9/2081 , A61K9/209 , A61K9/2095 , A61K9/282 , A61K9/2826 , A61K9/284 , A61K9/286 , A61K9/2873 , A61K9/2886 , A61K9/2893 , A61K9/5084 , B30B11/08 , B30B11/34 , B30B15/302 , Y10T428/1352
摘要: A dosage form comprises: (a) at least one active ingredient; (b) a core; and(c) a shell which surrounds the core, wherein the shell is substantially free of pores having a diameter of 0.5-5.0 microns, and the shell comprises a first shell portion and a second shell portion which are compositionally different and the dosage form provides a modified release profile of the active ingredient upon contacting of the dosage form with a liquid medium. In another embodiment, the dosage form comprises: (a) at least one active ingredient; (b) a core comprising first and second core portions; and (c) a shell which surrounds the core, wherein the shell comprises first and second shell portions such that the first shell portion resides upon the first core portion and the second shell portion resides upon the second core portion, and at least one of the first or second shell portions or first or second shell portions provides a modified release profile of the active ingredient upon contacting of the dosage form with a liquid medium.
-
公开(公告)号:EP1545452A1
公开(公告)日:2005-06-29
申请号:EP03716788.9
申请日:2003-03-21
申请人: McNeil-PPC, Inc.
发明人: LI, Shun-Por , LEE, Der-Yang , MCNALLY, Gerard, P. , MCTEIGUE, Daniel , PARIKH, Narendra , SOWDEN, Harry, S. , WYNN, David
IPC分类号: A61K9/00
CPC分类号: A61K9/284 , A61K9/0004 , A61K9/2072 , A61K9/2077 , A61K9/2095 , A61K9/2893
摘要: A dosage form comprises: (a) at least one active ingredient; (b) a core having an outer surface; and (c) a shell which resides upon at least a portion of the core outer surface, wherein at least a portion of the shell is semipermeable, such that the liquid medium diffuses through the semipermeable shell or shell portion to the core due to osmosis. The shell also provides for delivery of the active ingredient to a liquid medium outside the shell after contacting of the dosage form with the liquid medium. The dosage form delivers one or more active ingredients in a controlled manner upon contacting of the dosage form with a liquid medium. The dosage form may be employed to provide a burst release of the active ingredient, or to provide release of the active ingredient at an ascending release rate over an extended time period upon contacting of the dosage form with a liquid medium.
-
公开(公告)号:EP1429915A1
公开(公告)日:2004-06-23
申请号:EP02773600.8
申请日:2002-09-26
申请人: McNeil-PPC, Inc.
发明人: SOWDEN, Harry, S. , LI, Shun-Por
CPC分类号: A61J3/10 , A23G3/04 , A23G3/368 , A61J3/005 , A61K9/2853 , A61K9/2873 , A61K9/2893 , B30B11/08 , B30B11/34
摘要: In one embodiment, a dosage form comprises: (a) at least one active ingredient; (b) a molded core which is solid at room temperature; and (c) a shell which is in contact with at least a portion of the core, wherein the dosage form provides modified release of the active ingredient upon contacting of the dosage form with a liquid medium. In another embodiment of this invention, a dosage form comprises: (a) at least one active ingredient; (b) a molded core comprising a plurality of particles; and (c) a shell which is in contact with at least a portion of the core, wherein the dosage form provides modified release of the active ingredient upon contacting of the dosage form with a liquid medium.
-
公开(公告)号:EP1438030A2
公开(公告)日:2004-07-21
申请号:EP02799689.1
申请日:2002-09-28
申请人: McNEIL-PPC, INC.
发明人: LEE, Der-Yang , LI, Shun-Por , SOWDEN, Harry, S. , THOMAS, Martin , WYNN, David
IPC分类号: A61K9/28
CPC分类号: A23G3/04 , A23G1/54 , A23G3/0029 , A23G3/368 , A23G3/54 , A23L29/30 , A61J3/005 , A61J3/06 , A61J3/10 , A61K9/0004 , A61K9/0056 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2031 , A61K9/2054 , A61K9/2068 , A61K9/2072 , A61K9/2081 , A61K9/209 , A61K9/2095 , A61K9/282 , A61K9/2826 , A61K9/284 , A61K9/286 , A61K9/2873 , A61K9/2886 , A61K9/2893 , A61K9/5084 , B30B11/08 , B30B11/34 , B30B15/302 , Y10T428/1352
摘要: A dosage form comprises: (a) at least one active ingredient: (b) a core having a first surface portion upon which resides a first coating and a second surface portion which is substantially free of the first coating; and (c) a shell which resides upon at least a portion of the second surface portion, wherein the shell comprises a different material from the first coating. In another embodiment, the dosage form comprises: (a) at least one active ingredient; (b)a core comprising a center portion having an exterior surface and an annular portion having an exterior surface and an interior surface, wherein the annular portion interior surface is in contact with at least a portion of the center portion exterior surface, and a coating resides on at least a portion of the annular portion exterior surface; and (c) a shell which resides upon at least a portion of the exterior surface of the center portion, wherein the shell comprises a different material than the impermeable coating. In another embodiment, the dosage form comprises: (a) at least one active ingredient; (b) a core having an outer surface and a cavity which extends at least partially through the core such that the core outer surface has at least a first opening therein; (c) a first coating which resides on at least a portion of the core outer surface, wherein the first shell portion comprises a different material from the first coating; and (d) a first shell portion which is adjacent to the first opening and covers at least the first opening.
-
公开(公告)号:EP1432378A1
公开(公告)日:2004-06-30
申请号:EP02768902.5
申请日:2002-09-26
申请人: McNEIL-PPC, INC.
IPC分类号: A61J3/00
CPC分类号: A23G3/368 , A23G3/04 , A61J3/005 , A61J3/06 , A61J3/10 , A61K9/2853 , A61K9/2873 , A61K9/2893 , B30B11/005
-
公开(公告)号:EP1429915B1
公开(公告)日:2009-01-14
申请号:EP02773600.8
申请日:2002-09-26
申请人: McNEIL-PPC, Inc.
发明人: SOWDEN, Harry, S. , LI, Shun-Por
CPC分类号: A61J3/10 , A23G3/04 , A23G3/368 , A61J3/005 , A61K9/2853 , A61K9/2873 , A61K9/2893 , B30B11/08 , B30B11/34
摘要: In one embodiment, a dosage form comprises: (a) at least one active ingredient; (b) a molded core which is solid at room temperature; and (c) a shell which is in contact with at least a portion of the core, wherein the dosage form provides modified release of the active ingredient upon contacting of the dosage form with a liquid medium. In another embodiment of this invention, a dosage form comprises: (a) at least one active ingredient; (b) a molded core comprising a plurality of particles; and (c) a shell which is in contact with at least a portion of the core, wherein the dosage form provides modified release of the active ingredient upon contacting of the dosage form with a liquid medium.
-
公开(公告)号:EP1432378B1
公开(公告)日:2008-12-31
申请号:EP02768902.5
申请日:2002-09-26
申请人: McNEIL-PPC, Inc.
IPC分类号: A61J3/00
CPC分类号: A23G3/368 , A23G3/04 , A61J3/005 , A61J3/06 , A61J3/10 , A61K9/2853 , A61K9/2873 , A61K9/2893 , B30B11/005
-
公开(公告)号:EP1438028A1
公开(公告)日:2004-07-21
申请号:EP02799682.6
申请日:2002-09-28
申请人: McNEIL-PPC, INC.
发明人: LEE, Der-Yang , LI, Shun-Por , SOWDEN, Henry, S. , THOMAS, Martin , WYNN, David
IPC分类号: A61K9/20
CPC分类号: A23G3/04 , A23G1/54 , A23G3/0029 , A23G3/368 , A23G3/54 , A23L29/30 , A61J3/005 , A61J3/06 , A61J3/10 , A61K9/0004 , A61K9/0056 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2031 , A61K9/2054 , A61K9/2068 , A61K9/2072 , A61K9/2081 , A61K9/209 , A61K9/2095 , A61K9/282 , A61K9/2826 , A61K9/284 , A61K9/286 , A61K9/2873 , A61K9/2886 , A61K9/2893 , A61K9/5084 , B30B11/08 , B30B11/34 , B30B15/302 , Y10T428/1352
摘要: In one embodiment a dosage form comprises at least one active ingredient and a molded matrix which comprises from 10 to 100% of a material having a melting point of less than about 100 degrees C selected from the stamp consisting of thermoplastic polyalkylene oxides, low melting hydrophobic materials, thermoplastic polymers, thermoplastic starches and combinations thereof, and the matrix is capable of providing modified release of the active ingredient upon contacting of the dosage form with a liquid medium. The dosage form may additionally comprise uncoated particles which may contain at least one active ingredient. In another embodiment, a dosage form comprises at least one active ingredient, a plurality of particles and a molded matrix, wherein at least a portion of the particles are coated. The coated particles, the matrix or both may comprise at least one active ingredient, and the coated particles or the matrix or a combination thereof is capable of providing modified release of the active ingredient upon contacting of the dosage form with a liquid medium.
-
公开(公告)号:EP1429738A2
公开(公告)日:2004-06-23
申请号:EP02783988.5
申请日:2002-09-28
申请人: McNeil-PPC, INC.
发明人: LEE, Der-Yang , LI, Shun-Por , PARIKH, Narendra , SOWDEN, Harry, S. , THOMAS, Martin , WYNN, David
IPC分类号: A61K9/20
CPC分类号: A23G3/04 , A23G1/54 , A23G3/0029 , A23G3/368 , A23G3/54 , A23L29/30 , A61J3/005 , A61J3/06 , A61J3/10 , A61K9/0004 , A61K9/0056 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2031 , A61K9/2054 , A61K9/2068 , A61K9/2072 , A61K9/2081 , A61K9/209 , A61K9/2095 , A61K9/282 , A61K9/2826 , A61K9/284 , A61K9/286 , A61K9/2873 , A61K9/2886 , A61K9/2893 , A61K9/5084 , B30B11/08 , B30B11/34 , B30B15/302 , Y10T428/1352
摘要: A dosage form comprises: (a) a core comprising at least one active ingredient; and (b) a molded shell which surrounds the core, wherein the shell provides a predetermined time delay of greater than one hour for the onset of dissolution of the active ingredient upon contacting of the dosage form with a liquid medium and the delay is independent of the pH of the liquid medium. The weight of the shell may be at least 50 percent of the weight of the core, and the shell may have a thickness of about 500-4000 microns, or be substantially free of pores having a diameter of 0.5 to 5 microns.
摘要翻译: 剂型包含:(a)包含至少一种活性成分的核心; 和(b)围绕核心的模制外壳,其中该外壳提供大于一小时的预定时间延迟,用于活性成分在剂型与液体介质接触时开始溶解,延迟独立于 液体介质的pH值。 壳的重量可以是芯的重量的至少50%,并且壳可以具有约500-4000微米的厚度,或者基本上不具有直径为0.5-5微米的孔。
-
公开(公告)号:EP2364143A1
公开(公告)日:2011-09-14
申请号:EP09752583.6
申请日:2009-10-28
申请人: McNeil-PPC, Inc.
发明人: CHEN, Vincent , LI, Shun-Por , SHEN, Robert , LEE, Der-Yang
CPC分类号: A61K9/209 , A61K9/0004
摘要: The present invention features a method of manufacturing an osmotic tablet including the steps of (i) compressing a tablet core including a first pharmaceutically active agent and a hydrophilic polymer; (ii) applying an osmotic coating to the outer surface of the tablet core to form a coated tablet, wherein the osmotic coating includes at least one opening exposing the tablet core; and (iii) compressing an immediate release coating onto the surface of the coated tablet, wherein the release coating includes a second pharmaceutically active agent.
-
-
-
-
-
-
-
-
-